Biological variations in plasma VEGF and VEGFR-1 may compromise their biomarker value in colorectal cancer

Mads Nordahl Svendsen, Nils Brünner, Ib J Christensen, Henriette Ytting, Camilla Bentsen, Anne Fog Lomholt, Hans J Nielsen

5 Citationer (Scopus)

Abstrakt

Vascular Endothelial Growth Factor (VEGF) plays a prominent role in tumor angiogenesis and plasma VEGF concentration may carry prognostic information in colorectal cancer. The VEGF receptor 1 (VEGFR-1) is a regulatory receptor which is shredded into plasma of patients with colorectal cancer. For both molecules, large biological variation and lack of standardization of assay procedures are major challenges.
OriginalsprogEngelsk
TidsskriftScandinavian Journal of Clinical & Laboratory Investigation
Vol/bind70
Udgave nummer7
Sider (fra-til)503-11
Antal sider9
ISSN0036-5513
DOI
StatusUdgivet - 1 nov. 2010

Fingeraftryk

Dyk ned i forskningsemnerne om 'Biological variations in plasma VEGF and VEGFR-1 may compromise their biomarker value in colorectal cancer'. Sammen danner de et unikt fingeraftryk.

Citationsformater